Search results for " fibrillation"

showing 10 items of 478 documents

Atherothrombosis and Thromboembolism: Position Paper from the Second Maastricht Consensus Conference on Thrombosis

2018

AbstractAtherothrombosis is a leading cause of cardiovascular mortality and long-term morbidity. Platelets and coagulation proteases, interacting with circulating cells and in different vascular beds, modify several complex pathologies including atherosclerosis. In the second Maastricht Consensus Conference on Thrombosis, this theme was addressed by diverse scientists from bench to bedside. All presentations were discussed with audience members and the results of these discussions were incorporated in the final document that presents a state-of-the-art reflection of expert opinions and consensus recommendations regarding the following five topics: 1. Risk factors, biomarkers and plaque inst…

0301 basic medicinemedicine.medical_specialtyanticoagulantsADJUST ANTIPLATELET THERAPYPERCUTANEOUS CORONARY INTERVENTION030204 cardiovascular system & hematologyarterial thrombosisArticleantiplatelet therapyACTIVATED PROTEIN-CRED-BLOOD-CELLS03 medical and health sciences0302 clinical medicineVITAMIN-K ANTAGONISTSInternal medicineatherothrombosisIschaemic strokeNONVALVULAR ATRIAL-FIBRILLATIONmedicinePlateletatrial fibrillationACUTE ISCHEMIC-STROKEcoagulationATOMIC-FORCE MICROSCOPYCardiovascular mortalityischaemic strokeAtomic force microscopybusiness.industryConsensus conferenceHematologymedicine.diseaseThrombosis030104 developmental biologymyocardial infarctionCoagulationplateletsDIRECT ORAL ANTICOAGULANTSCardiologyPosition paperSYMPTOMATIC VENOUS THROMBOEMBOLISMatherosclerosisbusiness
researchProduct

2015

Background Atrial fibrillation (AF), whether silent or symptomatic, is a frequent and severe complication of acute myocardial infarction (AMI). Asymmetric dimethylarginine (ADMA), an endogenous eNOS inhibitor, is a risk factor for endothelial dysfunction. We addressed the relationship between ADMA plasma levels and AF occurrence in AMI. Methods 273 patients hospitalized for AMI were included. Continuous electrocardiographic monitoring (CEM) ≥48 hours was recorded and ADMA was measured by High Performance Liquid Chromatography on admission blood sample. Results The incidence of silent and symptomatic AF was 39(14%) and 29 (11%), respectively. AF patients were markedly older than patients wit…

0303 health sciencesmedicine.medical_specialtyMultidisciplinaryEjection fractionbusiness.industryAtrial fibrillation030204 cardiovascular system & hematologymedicine.disease3. Good healthCoronary artery disease03 medical and health scienceschemistry.chemical_compound0302 clinical medicinechemistryHeart failureInternal medicineHeart ratemedicineCardiologyMyocardial infarctionEndothelial dysfunctionAsymmetric dimethylargininebusiness030304 developmental biologyPLOS ONE
researchProduct

Population-based cohort study of warfarin-treated patients with atrial fibrillation: incidence of cardiovascular and bleeding outcomes

2014

OBJECTIVES: Atrial fibrillation (AF) is the most common cardiac rhythm disorder with a significant health burden. The aim of this study was to characterise patients with recently diagnosed AF and to estimate the rates of comorbidities and outcome events requiring hospitalisation in routine clinical practice. DESIGN: Pharmacoepidemiological cohort study using observational data. METHODS/SETTING: This study included 16 513 patients with a first diagnosis of AF between 1 January 2005 and 28 February 2010 (newly diagnosed patients) using data from the UK Clinical Practice Research Datalink (CPRD) linked to Hospital Episode Statistics (HES) and the Office for National Statistics mortality data. …

1683AdultMalemedicine.medical_specialtyPediatricsmedicine.drug_classPopulationCardiologyHemorrhageCardiovascular MedicineCohort StudiesYoung AdultAtrial FibrillationEpidemiologymedicine1724Humans1506educationStrokeAgedAged 80 and overeducation.field_of_studybusiness.industryResearchIncidenceIncidence (epidemiology)WarfarinAnticoagulantsThrombosisGeneral MedicineMiddle AgedVitamin K antagonistmedicine.disease1692Cardiovascular DiseasesEmergency medicineFemaleWarfarinDiagnosis codebusinessCohort studymedicine.drug
researchProduct

ATRIAL FIBRILLATION AND MILD COGNITIVE IMPAIRMENT: WHAT CORRELATION?

2006

ATRIAL FIBRILLATION AND MILD COGNITIVE IMPAIRMENT: WHAT CORRELATION? Aim. Atrial fibrillation (AF), in addition to macroembolic complications, may also produce multiple cerebral ischemic areas due to microembolic phenomena and transient hypoperfusion, eventually leading to a progressive cognitive impairment and even to acclaimed vascular dementia. The aim of this study was to evaluate the prevalence of cognitive impairment in patients with AF. The reported results concern data obtained at the moment of recruitment. Methods. The authors studied 42 patients with a history of non valvular AF (paroxysmal, persistent, recurrent or permanent) and 40 homogenous controls in sinus rhythm without pre…

ATRIAL FIBRILLATION AND MILD COGNITIVE IMPAIRMENT: WHAT CORRELATIONAtrial Fibrillation cognitive impairment Cognition Neuropsychological TestsSettore MED/11 - Malattie Dell'Apparato Cardiovascolare
researchProduct

Factors affecting basket catheter detection of real and phantom rotors in the atria: A computational study

2018

[EN] Anatomically based procedures to ablate atrial fibrillation (AF) are often successful in terminating paroxysmal AF. However, the ability to terminate persistent AF remains disappointing. New mechanistic approaches use multiple-electrode basket catheter mapping to localize and target AF drivers in the form of rotors but significant concerns remain about their accuracy. We aimed to evaluate how electrode-endocardium distance, far-field sources and inter-electrode distance affect the accuracy of localizing rotors. Sustained rotor activation of the atria was simulated numerically and mapped using a virtual basket catheter with varying electrode densities placed at different positions withi…

Ablation TechniquesNormalization propertyTime FactorsPhysiologymedicine.medical_treatmentAction Potentials02 engineering and technology030204 cardiovascular system & hematologylaw.invention0302 clinical medicineModelslawHeart RateMedicine and Health SciencesMapping cathetersCardiac Atrialcsh:QH301-705.5Numerical AnalysisEcologyRotor (electric)HeartAblationElectrophysiologyComputational Theory and Mathematicsmedicine.veinModeling and SimulationRotorsPhysical SciencesInferior Vena CavaEngineering and TechnologyAnatomyBasket catheterArrhythmiaInterpolationResearch ArticleBiotechnologyMaterials scienceCatheters0206 medical engineeringPhase (waves)CardiologyInferior vena cavaModels BiologicalMembrane PotentialImaging phantomVeinsTECNOLOGIA ELECTRONICA03 medical and health sciencesCellular and Molecular NeuroscienceAblation Techniques; Action Potentials; Atrial Fibrillation; Computational Biology; Computer Simulation; Heart Atria; Heart Conduction System; Heart Rate; Humans; Models Biological; Time FactorsHeart Conduction SystemPhase analysisGeneticsmedicineHumansComputer SimulationHeart AtriaMolecular BiologyEcology Evolution Behavior and SystematicsMechanical EngineeringComputational BiologyBiology and Life SciencesBiological020601 biomedical engineeringAtrial fibrillationInterpolationlcsh:Biology (General)Cardiovascular AnatomyBlood VesselsMedical Devices and EquipmentMathematicsBiomedical engineeringEndocardium
researchProduct

Impact of monitoring on detection of arrhythmia recurrences in the ESC-EHRA EORP atrial fibrillation ablation long-term registry

2019

Abstract Aims Monitoring of patients after ablation had wide variations in the ESC-EHRA atrial fibrillation ablation long-term (AFA-LT) registry. We aimed to compare four different monitoring strategies after catheter AF ablation. Methods and results The ESC-EHRA AFA-LT registry included 3593 patients who underwent ablation. Arrhythmia monitoring during follow-up was performed by 12-lead electrocardiogram (ECG), Holter ECG, trans-telephonic ECG monitoring (TTMON), or an implanted cardiac monitoring (ICM) system. Patients were selected to a given monitoring group according to the most extensive ECG tool used in each of them. Comparison of the probability of freedom from recurrences was perfo…

Ablation Techniquesmedicine.medical_specialtymedicine.medical_treatmentAftercareKaplan-Meier EstimateElectrocardiographyRecurrencePhysiology (medical)Internal medicineAtrial FibrillationmedicineHumansTelemetryRegistriescardiovascular diseasesMonitoring methodsbusiness.industryCardiac arrhythmiaAtrial fibrillationmedicine.diseaseAblationTelephoneEcg monitoringCatheterElectrocardiography AmbulatoryCardiologyCardiac monitoringCardiology and Cardiovascular MedicinebusinessHolter ecgEP Europace
researchProduct

Baseline CHA 2 DS 2 ‐VASc score and prognosis in octogenarians with non‐ST segment elevation acute coronary syndrome

2021

Background CHA2DS2-VASc Score is widely used to predict thromboembolic risk in patients with Atrial Fibrillation (AF). We sought to study if this score predicts outcomes in elderly patients with Non-ST segment Elevation Acute Coronary Syndromes (NSTEACS). Methods The multicenter LONGEVO-SCA prospective registry included 532 unselected patients with NSTEACS aged ≥80 years. Data to calculate CHA2DS2-VASc Score were available in 523 patients (98.3%). They were classified according to CHA2DS2-VASc Score: group 1 (score ≤ 4), and 2 (5-9). We studied outcomes in terms of mortality or readmission at 6 months follow-up. Results A total of 266 patients (51%) had a high CHA2DS2-VASc Score (group 2). …

Acute coronary syndromemedicine.medical_specialtyEjection fractionbusiness.industryGerontologíaEnfermedad cardiovascularAtrial fibrillationGeneral Medicinemedicine.diseaseHeart failureInternal medicineCHA2DS2–VASc scoremedicineCardiologyST segmentSíndrome coronario agudoInfarto de miocardiobusinessStrokeKillip classInternational Journal of Clinical Practice
researchProduct

Stroke Incidence and Death in Atrial Fibrillation Patients Newly Treated with Direct Oral Anticoagulants.

2021

Amélie Gabet,1 Edouard Chatignoux,1 Clémence Grave,1 Alexandre Vallée,2 Philippe Tuppin,3 Yannick Béjot,4 Valérie Olié1 1French Public Health Agency, Saint-Maurice, France; 2Diagnosis and Therapeutic Center, Hotel Dieu, AP-HP, University Paris Descartes, Paris, France; 3General Health Insurance Scheme (Caisse Nationale d’Assurance Maladie), Paris, France; 4Dijon Stroke Registry, EA4184, University Hospital and Medical School of Dijon, University of Burgundy, Dijon, FranceCorrespondence: Amélie GabetFrench Public Health Agency, 14 rue du Val d’Osne, Saint Maurice, 94410, FranceTel +33155125164Fax…

Acute coronary syndromemedicine.medical_specialtyEpidemiologyPopulation030204 cardiovascular system & hematologyLower riskdirect oral anticoagulants03 medical and health sciences0302 clinical medicineInternal medicinedeathmedicineClinical EpidemiologyDecompensationatrial fibrillation030212 general & internal medicineadherenceeducationStrokeOriginal Researcheducation.field_of_studybusiness.industryAtrial fibrillationRetrospective cohort studymedicine.diseasestrokeHeart failurebusinessClinical epidemiology
researchProduct

Risk factors, atrial fibrillation and thromboembolic events.

2008

AIM: The aim of this study was to evaluate the relation between risk factors for atrial fibrillation (AF) and thromboembolic complications. METHODS: We studied 480 patients (mean age: 71.2+/-11.6 years): 240 with paroxysmal AF, 240 with permanent AF. The association between AF and the presence of risk factors, cardiac and systemic disease was observed and the correlation with the occurrence of complications analyzed. RESULTS: Patients with AF had a high prevalence of the following conditions: hypertension, hypertensive heart disease (HHD), coronary artery disease, hyperthyroidism. Thromboembolism was observed in 26.6% of the patients. A correlation between the occurrence of a thromboembolic…

AdultAged 80 and overMaleHypercholesterolemiaSmokingFibrinogenMiddle Agedatrial fibrillation risk factorsCohort StudiesDiabetes ComplicationsYoung AdultRisk FactorsThromboembolismAtrial FibrillationHypertensionHumansFemaleObesityAgedInternational angiology : a journal of the International Union of Angiology
researchProduct

Wall motion characteristic of the right pulmonary artery in the suprasternal echocardiogram

1980

This study describes the motion pattern of the right pulmonary artery (RPA) as it can be assessed from the suprasternal echocardiogram. The motion characteristic of the RPA is dependent on hemodynamic factors within the lumen of the RPA and those within the left atrium and the aortic arch. During atrial contraction the superior wall of the left atrium separates from the inferior wall of the RPA (IWRPA) and produces an "a" dip in the wall motion of the IWRPA. During isovolumic contraction the RPA is shifted upward (IC point). The incisura in the pulmonary artery pressure curve reflecting pulmonic valve closure can be seen by a sudden decrease in the diameter of the RPA (PC point). In conditi…

AdultAortic archmedicine.medical_specialtyHeart DiseasesHypertension PulmonaryMovementAortic Valve InsufficiencyLumen (anatomy)HemodynamicsPulmonary Arterycomplex mixturesInternal medicinemedicine.arteryAtrial FibrillationHumansMedicineRadiology Nuclear Medicine and imagingWall motionIsovolumetric contractionbusiness.industryHemodynamicsMitral Valve InsufficiencyAnatomyMiddle AgedRight pulmonary arteryenzymes and coenzymes (carbohydrates)Heart BlockEchocardiographyPulmonary arteryInferior wallCardiologybusinessJournal of Clinical Ultrasound
researchProduct